Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Drug Controller General of India
Manufacturing
With supplies tight, India nixes remdesivir exports: reports
India is axing exports of Gilead Sciences' pandemic antiviral remdesivir, thanks to skyrocketing demand and a spike in local COVID infections.
Fraiser Kansteiner
Apr 12, 2021 10:00am
India loses patience as drugmakers stall on fixed-dose combo studies
Sep 8, 2016 8:17am
India slated for sales of Opdivo, Keytruda head-to-head
Aug 7, 2016 10:37pm
India plans massive drug manufacturing inspection effort
Jun 22, 2016 10:09am
Roche challenges India regulator on Avastin biosimilar
May 18, 2016 5:35am
India updates on manufacture suspension for antifungal therapy
May 11, 2016 9:33pm
